New York, NY — In a landmark recognition of scientific excellence, Dr. Miriam Merad, MD, PhD, a distinguished immunologist and...

Christopher Kane, MD, a distinguished figure in urology and the current CEO of the UC San Diego Health Physician Group,...

Liver cancer remains one of the most formidable challenges in oncology, with hepatocarcinoma—or hepatocellular carcinoma (HCC)—standing as its most commonly...

In recent years, the “obesity paradox” has challenged long-standing assumptions about body weight and health outcomes, particularly in cardiovascular disease....

A groundbreaking study from Queen Mary University of London has unveiled stark disparities in breast cancer outcomes among women of...

In a groundbreaking advancement in breast cancer screening, researchers have identified that abbreviated breast magnetic resonance imaging (MRI) protocols can...

In the challenging landscape of pancreatic ductal adenocarcinoma (PDAC) treatment, surgical resection remains a cornerstone despite the high risk of...

In a remarkable advance in cancer immunotherapy, a novel targeted immune treatment has brought lasting remission to a patient suffering...

In a landmark advancement poised to reshape prognostic evaluation in epithelial ovarian cancer (EOC), researchers have successfully developed and validated...

In a groundbreaking new study poised to reshape our understanding of prostate cancer progression, researchers have identified a critical mitochondrial...